Inceptionr LLC Intra Cellular Therapies, Inc. Transaction History
Inceptionr LLC
- $389 Billion
- Q1 2024
A detailed history of Inceptionr LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Inceptionr LLC holds 7,575 shares of ITCI stock, worth $567,064. This represents 0.13% of its overall portfolio holdings.
Number of Shares
7,575Holding current value
$567,064% of portfolio
0.13%Shares
2 transactions
Others Institutions Holding ITCI
# of Institutions
384Shares Held
77.5MCall Options Held
1.7MPut Options Held
1.13M-
Vanguard Group Inc Valley Forge, PA9.23MShares$691 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.08MShares$605 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$289 Million1.4% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.82MShares$211 Million3.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.48MShares$185 Million2.06% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.07B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...